COMMUNIQUÉS West-GlobeNewswire

-
EDAP TMS SA : John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One® Technology for Prostate Tissue Ablation
03/01/2019 -
Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial
03/01/2019 -
Samumed Granted Orphan Drug Designation for SM08502 for the Treatment of Pancreatic Cancer
03/01/2019 -
Replimune Highlights Company Progress and Expected 2019 Milestones Ahead of Presentation at the 37th Annual JPMorgan Healthcare Conference
03/01/2019 -
Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening
03/01/2019 -
Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019 -
Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program
03/01/2019 -
Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014
03/01/2019 -
Cabaletta Bio Closes $50 Million Series B Financing to Establish Translational Research and Advanced Manufacturing Capabilities for Chimeric AutoAntibody Receptor (CAAR) T Cell Products to Treat B Cell-Mediated Autoimmune Diseases
03/01/2019 -
AC Immune Announces Appointment of Dr. Marie Kosco-Vilbois as Chief Scientific Officer
03/01/2019 -
MatriSys Bioscience Announces Initiation of Corporate IND for its MSB-01 with the FDA and new Microbiome formulation IP filing
03/01/2019 -
Verona Pharma Appoints Kathleen Rickard, MD, as Chief Medical Officer to Lead Late Stage Clinical Development of RPL554
03/01/2019 -
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to an Innovative Diagnostic Assay for Non-Alcoholic SteatoHepatitis (NASH)
03/01/2019 -
GENFIT et LabCorp signent un accord de licence visant l'élargissement de l'accès à un test diagnostique innovant de la stéatohépatite non-alcoolique (NASH)
03/01/2019 -
DBV Technologies Expands and Strengthens Leadership Team
03/01/2019 -
DBV Technologies étend et renforce son équipe de management
03/01/2019 -
Progenics and Curium Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
03/01/2019
Pages